why choose us

Clinical Trials Search

Showing 19,440 of 132,963 result(s)
Brain Stimulation Effects on Cognitive Task Performance

Status: Completed

Condition: Cognitive Function

Interventions: Transcranial Magnetic Stimulation (TMS) is a noninvasive method for stimulating neurons (axons not cell bodies) in the brain.

Date: 2022-09-20

Perioperative Steroid Dosing on the APR in AIS

Status: Completed

Condition: Adolescent Idiopathic Scoliosis (AIS)

Interventions:

Patients randomized to the dexamethasone cohort will be administered 8 mg of dexamethasone with 3 additional (8mg doses) administered at 8-hour int

Date: 2022-09-20

The Use of Photobiomodulation in the Treatment of Oral Complaints of Long COVID-19.A Randomized Controlled Trial.

Status: COMPLETED

Condition: Xerostomia

Interventions: (Medical follow-up at the general outpatient clinic for prescription and control of medications, underlying diseases, clinical status and routine shor

Date: 2022-09-20

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Status: COMPLETED

Condition: Neuromyelitis Optica Spectrum Disorder

Interventions: IV, once every 12 weeks (Q12W)

Date: 2022-09-20

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Status: COMPLETED

Condition: Hepatocellular Carcinoma

Interventions:

Atezolizumab 1200 mg and bevacizumab 15 mg;Kg is administered IV infusion every 3 weeks.

Proton beam therapy 30 - 50 Gy;5 fractions

Date: 2022-09-20

Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma

Status: COMPLETED

Condition: Perihilar Cholangiocarcinoma

Interventions: PROCEDURE: Endoluminal radiofrequency ablation - Endoluminal Radiofrequency ablation (RFA) of the entire stricture length will be performed using the

Date: 2022-09-20

A Study of Bomedemstat (MK-3543) in Participants With Polycythemia Vera (MK-3543-004)

Status: COMPLETED

Condition: Polycythemia Vera

Interventions: Oral tablet

Date: 2022-09-20

Metformin in Patients With Ulcerative Colitis Treated With Mesalamine

Status: COMPLETED

Condition: Inflammatory Bowel Diseases

Interventions: metformin group will take mesalamine 1 gm three times daily plus metformin 500 mg two times daily

Date: 2022-09-20

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Status: COMPLETED

Condition: Endometriosis

Interventions: OG-6219 Dose 1, Dose 2, Dose 3 BID: Participants will receive (orally) OG-6219 tablets during treatment cycles.

Date: 2022-09-20

Ritlecitinib for Cicatricial Alopecia

Status: COMPLETED

Condition: Cicatricial Alopecia

Interventions: tablets containing active drug (a combined JAK3;TEC inhibitor)

Date: 2022-09-19